Treatment of Cancer-anorexia Using Megestrol Acetate Concentrated Suspension in Lung or Pancreatic Cancer Patients

NCT00637728 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Difficulty finding the required patient population

Conditions

Anorexia
Cachexia
Weight Loss

Interventions

DRUG: Megestrol acetate concentrated suspension 110 mg/mL
DRUG: Placebo

Sponsor

Par Pharmaceutical, Inc.

Collaborators

[object Object]